Trials / Not Yet Recruiting
Not Yet RecruitingNCT06482398
Cream Containing Sericin and Turmeric in Psoriasis Patients
Efficacy and Safety of Cream Containing Sericin and Turmeric in Psoriasis Patients
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Psoriasis lesion is divided into two parts. Half of the lesion will apply cream containing sericin and turmeric and another will apply steroid cream (control). The samples will be apply two times a day for 8 weeks. Psoriasis area and severity index, physician global assessment, body surface area of lesion, dermatology life quality index, Itching score, adverse reaction are evaluated before, after using the samples for 4 and 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sericin extract and turmeric extract cream | Apply the sample 2 times a day for 8 weeks |
| DRUG | Triamcinolone acetonide 1% Cream | Apply the sample 2 times a day for 8 weeks |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-06-30
- Completion
- 2025-07-31
- First posted
- 2024-07-01
- Last updated
- 2024-07-01
Source: ClinicalTrials.gov record NCT06482398. Inclusion in this directory is not an endorsement.